Press release
Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Development, Quality Control, and Regulatory Compliance in Pharmaceutical Research
Estradiol Valerate EP Impurity A is a high-quality reference standard designed to meet the stringent requirements of pharmaceutical research, method validation, and quality control processes.Explore Estradiol Valerate EP Impurity A :
https://aquigenbio.com/product/estradiol-valerate-ep-impurity-a/
Manufactured and characterized with precision, this impurity standard supports laboratories and manufacturers in achieving consistent, reliable, and reproducible results in critical analytical workflows.
With its exceptional purity and accurate characterization, Estradiol Valerate EP Impurity A plays a vital role in analytical method development (AMD), method validation (AMV), routine quality control (QC), and regulatory submissions such as ANDA filings. It is particularly suitable for laboratories working with steroidal hormone formulations, ensuring compliance with pharmacopeial and regulatory guidelines.
Key Features and Benefits
High-purity reference standard, tested and validated to meet analytical and regulatory needs.
Supplied with a Certificate of Analysis (CoA) for traceability and quality assurance.
Stability-tested and packaged for safe, contamination-free handling and storage.
Suitable for various applications, including impurity profiling, stability testing, and process validation.
Globally available with efficient dispatch and secure shipping to support urgent project timelines.
Applications
Estradiol Valerate EP Impurity A is widely used across pharmaceutical operations, including:
Development and validation of analytical methods for estradiol valerate formulations.
Routine QC testing during drug manufacturing to ensure product integrity.
Support for regulatory submissions and audits, ensuring full compliance.
Research and stability studies in hormone-based drug development.
Safety and Handling
Aquigen Bio prioritizes the safety and compliance of all laboratory processes. Estradiol Valerate EP Impurity A is provided with a comprehensive Safety Data Sheet (SDS) to guide safe use.
Key safety practices include:
Using appropriate personal protective equipment (gloves, goggles, lab coats).
Handling the material in a well-ventilated area or under a fume hood.
Proper labeling and dedicated storage to prevent cross-contamination.
Explore Estradiol Valerate Impurities :
https://aquigenbio.com/products/impurity-standards/estradiol-valerate/
Following regulated waste disposal procedures in accordance with local guidelines.
Why Choose Estradiol Valerate EP Impurity A from Aquigen Bio
Uncompromised Accuracy: Precisely characterized to deliver reliable analytical results.
Regulatory-Ready Documentation: Complete CoA and SDS to meet stringent audit and filing requirements.
Global Reach and Fast Fulfillment: Ready stock and rapid dispatch to keep projects on schedule.
Technical Support: Expert guidance for application-related queries and compliance support.
Related Products
To support comprehensive analytical needs, Aquigen Bio also offers:
Estradiol Valerate EP Impurity B - Another critical impurity standard for enhanced profiling and validation.
https://aquigenbio.com/product/estradiol-valerate-ep-impurity-b/
Estradiol Valerate (Parent Compound) - The main API standard, ideal for research, development, and routine QC applications.
https://aquigenbio.com/product/estradiol-valerate/
Contact:
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com
About Aquigen Bio Sciences
Aquigen Bio Sciences is at the forefront of pharmaceutical excellence, serving as the leading resource for Estradiol Valerate impurity standards in India. With a strong commitment to safety, innovation, and regulatory compliance, the organization specializes in impurity profiling, synthesis, and analysis, empowering pharmaceutical manufacturers globally with premier standards. Aquigen Bio Sciences' dedication to cutting-edge research ensures it remains a trusted partner in refining quality benchmarks across the pharmaceutical landscape.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Development, Quality Control, and Regulatory Compliance in Pharmaceutical Research here
News-ID: 4159800 • Views: …
More Releases from Aquigen Bio Sciences

High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deute …
Product Overview
N-Nitroso Betahistine D3 is a premium deuterated nitrosamine impurity standard, specifically developed for precise analytical testing in pharmaceutical laboratories. This reference standard is widely used for analytical method development, validation, and quality control processes to meet stringent regulatory guidelines. With exceptional purity, complete documentation, and reliable traceability, it is ideal for research, development, and compliance applications.
https://aquigenbio.com/product/n-nitroso-betahistine-d3/
Key Features and Benefits
Deuterated Design for Precision: The incorporation of deuterium improves mass spectrometric…

Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control.
Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.…

Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance.
Why Harmine Impurity Standards Matter
https://aquigenbio.com/products/impurity-standards/harmine/
Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has…

AquigenBio Introduces High-Purity Daridorexant Hydrochloride to Support Sleep Di …
India - August 2025 - AquigenBio, a premier provider of pharmaceutical reference standards and impurity profiling solutions, proudly announces the release of Daridorexant Hydrochloride (CAS No. 1792993-84-0). This high-quality, precisely characterized compound is a hydrochloride salt form of Daridorexant, a dual orexin receptor antagonist with proven efficacy in the treatment of insomnia.
Explore Daridorexant Hydrochloride -
https://aquigenbio.com/product/daridorexant-hydrochloride/
The launch of this product marks a significant addition to AquigenBio's growing portfolio of sleep…
More Releases for Estradiol
Estradiol Transdermal Patches Market Growth Driven by Hormonal Imbalance Therapi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Estradiol Transdermal Patches Market- (By Type (25 Mg/Day, 50 Mg/Day, 75 Mg/Day, and 100 Mg/Day) By Gender (Male, and, Female), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Estradiol Transdermal Patches Market is valued at USD 1.8 Bn in 2024, and it is…
Estradiol Gel Market Size And Global Industry Forecast 2034
" As of 2024, the global estradiol gel market is valued at approximately USD 1.2 billion. Anticipating robust growth, the market is projected to reach around USD 2.5 billion by 2034, driven by increasing awareness regarding menopause management, rising geriatric populations, and growing adoption of hormone replacement therapy. This trajectory indicates a Compound Annual Growth Rate (CAGR) of approximately 7.6% from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report…
Global Desogestrel And Ethinyl Estradiol Tablets Market Size by Application, Typ …
USA, New Jersey- According to Market Research Intellect, the global Desogestrel And Ethinyl Estradiol Tablets market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Growing knowledge of contraceptive methods and their part in family planning is driving demand for desogestral and ethinyl estradiol tablets to rise.…
Estradiol Market 2024 (Latest Report) to Witness Major Growth in Upcoming Year
Estradiol Market Overview 2024:
The Latest Report on the Global Estradiol Market provides a comprehensively analysis of the market on a regional level and global. The report includes market trends, Market size, market share, growth drivers, competitive landscape, and regional data. The Estradiol Market size is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period from 2024-2031. It offers comprehensive coverage of the market…
Global Ethynyl Estradiol (EE) Market Research Report 2023-2029
Global Ethynyl Estradiol (EE) Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the future. The information presented is based on historical milestones and current…
Estradiol Transdermal Patches Market Value Projected to Expand by 2029
Estradiol transdermal patches market is anticipated to grow at a significant CAGR during the forecast period. Estradiol is a form of estrogen which is a female sex hormone produced by the ovaries necessary for many processes in the body. Additionally, estradiol transdermal patches are used for the treatment of certain symptoms of menopause such as hot flashes, vaginal dryness, burning, and irritation. The major factor driving the demand for estradiol…